BMY - BRISTOL MYERS SQUIBB CO
62.33
1.110 1.781%
Share volume: 12,306,233
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$61.22
1.11
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 04-25-2024 | 07-26-2024 | 10-31-2024 | 02-12-2025 | 04-24-2025 | 07-31-2025 | 10-30-2025 | 02-11-2026 | |
| Assets | |||||||||
| Total Assets | 99.031 B | 94.646 B | 93.670 B | 92.603 B | 92.427 B | 94.676 B | 96.889 B | 90.038 B | |
| Current Assets | 28.669 B | 26.890 B | 28.075 B | 29.780 B | 30.783 B | 33.222 B | 35.630 B | 29.390 B | |
| Inventories | 2.985 B | 3.077 B | 3.332 B | 2.557 B | 2.666 B | 2.737 B | 2.758 B | 2.690 B | |
| Other Current Assets | 5.567 B | 5.737 B | 5.623 B | 5.617 B | 5.534 B | 5.466 B | 4.948 B | 4.613 B | |
| Short Term Investments | 340.000 M | 360.000 M | 204.000 M | 513.000 M | 907.000 M | 1.004 B | 776.000 M | 464.000 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 9.330 B | 6.293 B | 7.890 B | 10.346 B | 10.875 B | 12.599 B | 15.726 B | 10.209 B | |
| Total Non-current Assets | 367.000 M | 357.000 M | 324.000 M | 320.000 M | 344.000 M | 346.000 M | 406.000 M | 396.000 M | |
| Property Plant Equipment | 6.750 B | 6.845 B | 6.903 B | 7.136 B | 7.213 B | 7.373 B | 7.349 B | 7.543 B | |
| Other Assets | 63.612 B | 60.911 B | 58.692 B | 55.687 B | 54.430 B | 54.083 B | 53.909 B | 53.105 B | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 99.031 B | 94.646 B | 93.670 B | 92.603 B | 92.427 B | 94.676 B | 96.889 B | 90.038 B | |
| Total liabilities | 82.483 B | 77.577 B | 76.470 B | 76.215 B | 74.979 B | 77.187 B | 78.289 B | 71.533 B | |
| Total current liabilities | 25.822 B | 23.265 B | 22.638 B | 23.774 B | 24.070 B | 27.528 B | 28.136 B | 23.417 B | |
| Accounts Payable | 3.539 B | 3.751 B | 3.469 B | 3.602 B | 4.002 B | 5.427 B | 4.288 B | 3.575 B | |
| Other liabilities | 6.732 B | 4.993 B | 4.728 B | 4.469 B | 4.477 B | 4.942 B | 5.459 B | 5.043 B | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 49.487 B | 48.858 B | 48.674 B | 47.603 B | 46.157 B | 44.470 B | 44.469 B | 42.850 B | |
| Other liabilities | 6.732 B | 4.993 B | 4.728 B | 4.469 B | 4.477 B | 4.942 B | 5.459 B | 5.043 B | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 16.490 B | 17.015 B | 17.142 B | 16.335 B | 17.388 B | 17.436 B | 18.551 B | 18.472 B | |
| Common stock | 45.947 B | 46.058 B | 46.188 B | 46.316 B | 46.303 B | 46.426 B | 46.557 B | 46.679 B | |
| Retained earnings | 15.640 B | 16.103 B | 16.097 B | 14.912 B | 16.106 B | 16.154 B | 17.093 B | 16.896 B |